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1. Introduction
Designing antibiotic dosing regimens is often not optimal and the dose-response
relationship for most antibiotics is not well-known1. Both Pharmacokinetics (PK) and
Pharmacodynamics (PD) are characteristics of antimicrobial agents that should be
considered in the development of effective antibiotic therapy. By linking the concentration
time profile at the site of action to the drug effect (PK/PD), the effect of varying dosage
regimens against pathogens could be simulated enabling the identification of effective
dosage strategies. It is known that inadequate antibiotic dosing could not only lead to a
therapeutic failure, but also to the development of bacterial resistance. Importantly, the
evolution of resistance in pathogenic bacteria combined with the decreasing interest from
the pharmaceutical industry in developing new antibiotics has created a major public health
problem3. Therefore, the activities to maintain the effects of existing antibiotics and prolong
their useful life span have a high priority.
PK/PD analysis proved to be a useful tool for investigating effective therapies that minimize
the emergence of antibiotic tolerance. Although the European Medicine Agency and FDA
clearly recommends PK/PD assessment for new compounds, there are no standardized
procedures for such analyses for antibiotics3. For characterizing the PD of an antibiotic,
bacterial growth and death under antibiotic exposure have to be investigated. Since these are
difficult to measure in human tissues, animal and in vitro models have been developed.
Although animal models provide similar growth conditions for bacteria and imitate the
characteristics of human infection, they exhibit different PK and drug disposition profiles
compared to humans4. In contrast, in vitro models have the advantage of simulating human
PK and bacterial resistance analysis. Therefore, they are considered adequate for the
investigation of antimicrobial activity4.
Frequently, the pharmacodynmic relationship is reduced to a single parameter, the
Minimum inhibitory concentration (MIC), even though antibiotics with the same MIC can
*
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have different PD functions1. Differences in the kill profiles exhibited by antibiotics is
hypothesized to be influenced by disparities of their PD characteristics that- if not taken into
account during the design of treatment regimens- may lead to therapeutic failure and
development of resistance.
In this study, five antibiotics of five different classes were considered for PK/PD analysis.
The antibiotics were Ciprofloxacin (a fluorquinolone that acts by inhibiting bacterial DNA
gyrase enzyme), Ampicillin (a beta-lactam antibiotic acts by inhibiting bacterial cell wall
synthesis), and finally Rifampin, Streptomycin, and Tetracycline (protein synthesis
inhibitors). The antibiotics were further classified according to their pharmacodyamic
properties into concentration dependent antibiotics (Ciprofloxacin, Rifampin and
Streptomycin), and time dependent antibiotics (Ampicillin and Tetracycline).
PK/PD simulations using STELLA® (Version 9.1, isee system inc, NH, USA) were used to
investigate the effect of various PD parameters on the achievement of the therapeutic
outcome and in designing effective dosing regimen that help overcome the development of
resistance to the antibiotic.
2. Pharmacokinetic analysis
The PK of the antibiotics was assumed to follow one compartment disposition
characteristics with a first order elimination rate constant. The drug was given in a dose that
gave an initial plasma concentration equivalent to 5 times the MIC and the plasma
concentration was allowed to decrease mono-exponentially to a minimum of 0.5 times the
MIC over 8 hours according to the following equation
Ct=C0 exp{-kt}

(1)

Where Ct is the plasma concentration at time t, C0 is the initial plasma concentration and k is
the first-order elimination rate constant.
Doses were administered as multiple IV boluses with a time interval of 8 hours. The system
was assumed to be at a steady state. The volume of distribution was assumed to be fixed
(equals 1); since the data were obtained from an in vitro experiment. Clearance (k*v) was
then assumed to be equivalent to the value of the elimination rate constant k. For this
analysis, Ciprofloxacin, Ampicillin, Rifampin, Streptomycin and Tetracycline were the
considered antibiotics.
3. Pharmacodynamic analysis
3.1 Effect of exposure to antibiotics on the bacterial net growth rate
The net growth rate under certain antibiotic pressure could be described by the following
equation:( a )   max   ( a )

(2)

Where is the net growth rate at antibiotic concentration a, is the growth rate of the bacteria
in absence of antibiotic, and is the death rate of the bacterial population exposed to an
antibiotic concentration a. Therefore, the net growth rate of the bacterial population under
antibiotic treatment could be described by the following model:-
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(3)

Whereis the minimum net growth rate of the bacteria at high antibiotic concentration, a is
the antibiotic concentration, zMIC is the pharmacodynamic MIC (concentration of the
antibiotic at which the net bacterial growth rate was calculated to be zero), and K is the Hill
coefficient which is a measure of the steepness of the sigmoidal relationship between
antibiotic concentration and the net growth rate.
The model was constructed to evaluate the effect of the antibiotics against a single microorganism (E. coli); and therefore, the maximum growth rate is assumed to be constant.
The minimum growth rate, zMIC as well as the Hill coefficient will, however, change due to
different antibiotic treatments. Bacterial net growth rate against the antibiotic concentration
was analyzed for the aforementioned antibiotics.
4. PK/PD analyses

The bacterial population was modeled during the mono-exponential growth phase. The
change in bacterial density was modeled according to the following equation:dx/dt = growth rate – kill rate due to antibiotic
Where x is the bacterial density measures in colony forming units per mL (CFU/mL)
Time plots of the logarithm to the base 10 of the bacterial density were generated and the
effect of the PD parameters (MIC, K, minimum growth rate, and maximum growth rate) on
the achievement of the target treatment outcome was investigated through a sensitivity
analysis in STELLA®. The target treatment outcome was defined as three log10 decrease in
the bacterial density over a 24 hour course of the treatment.
4.1 Design of antibiotics treatment strategies

Antibiotics are generally classified to concentration dependent and time dependent agents.
In the current analysis, treatment strategies were constructed and tested under different
scenarios. Results from the simulation were used to conclude on the most appropriate
treatment option for different classes of antibiotics.
Increasing the MIC by two fold and four folds supported the simulation of bacterial
resistance against the antibiotic treatments. The outcome target of the treatment is to
achieve three log10 decrease in the bacterial density over a 24 hours course of treatment
through the given dosage regimen. Towards that target, two treatment strategies were
used. The first was to increase the area under the antibiotic concentration time curve
above the minimum inhibitory concentration (AUC>MIC) through increasing the
administered dose, while the second was to increase the percentage of time during which
the drug concentration is above the MIC relative to the dosing interval (% t>MIC) through
decreasing the dosing interval with smaller maintenance doses. Both scenarios were
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applied to each of the investigated antibiotics and the outcomes of the treatment regimens
were compared.
5. Results
5.1 The pharmacokinetic model

The disposition of the antibiotics was shown to follow a one compartment model with a first
order elimination rate. The achievement of the steady state was assumed form the beginning
of therapy. (Figure 1a and 1b)
The antibiotics were given as multiple intravenous boluses every 8 hours over a course of 24
hours.

v ol amp
conc amp
log conc Amp
amt Ampicillin

Amp dosing rate



Amp elim rate
cl amp

Fig. 1a. STELLA model simulating the one compartment PK model with first order
elimination rate constant for Ampicillin

Fig. 1b. Simulation of the Ampicillin steady state concentration time profile form the PK
model.

www.intechopen.com

Application of Pharmacokinetics/Pharmacodynamics
(PK/PD) in Designing Effective Antibiotic Treatment Regimens

115

5.2 Pharmacodynamic analysis
5.2.1 Effect of antibiotic concentration on the bacterial net growth rate

Changing antibiotic concentration is assumed to be affecting the net growth rate of the
bacteria cultured in the in vitro system. The infection was therefore assumed to occur in the
central compartment. The pharmacodynamic parameter estimates for the five considered
antibiotics are displayed in Table 1. STELLA model (Figure 2) was created to determine the
effect of changing drug concentration on the net bacterial growth rate according the
pharmacodynamic function expressed in equation 3.
PD parameter/
drug
Ciprofloxacin
Ampicillin
Rifampin
Streptomycin
Tetracycline

Max. growth
rate (h-1)
0.75
0.75
0.75
0.75
0.75

Min. growth
rate (h-1)
-6.5
-4.0
-4.3
-8.8
-8.1

K

zMIC (µg/mL)

1.1
0.75
2.5
1.9
0.61

0.017
3.4
12.0
18.5
0.67

Table 1. Pharmacodynamic parameter estimates1

Fig. 2. Sketch of the STELLA model used to assess the pharmacodynamic effect of the
antibiotic Ampicillin.
Bacterial net growth rate against the antibiotic concentration displayed a nonlinear
inhibitory PD function with increasing antibiotic concentration. It is assumed that the four
PD parameters (MIC, K, minimum growth rate, and maximum growth rate) contribute to
the shape of the PD curve.

www.intechopen.com

116

Readings in Advanced Pharmacokinetics – Theory, Methods and Applications

It is noticed that concentration dependent antibiotics (Ciprofloxacin, Rifampin, and
Streptomycin) showed a sharper decrease in the net growth rate in relation to antibiotic
concentration (greater K value), while time dependent antibiotics (Ampicillin and
Tetracycline) showed slower decline with respect to increase in concentration (lower K
values) (Figure 3). Additionally, Figure 4 shows that three antibiotics with the same MIC
values and minimum growth rate against a specific microorganism can have different
microbiological activity depending on the value of the Hill coefficient K.

Fig. 3. Effect of antibiotic concentration on bacterial net growth rate

Fig. 4. Pharmacodynamic sensitivity analysis shows the effect of three antibiotics with the
same MIC and minimum growth rate on the bacterial net growth rate due to different
values of Hill coefficient (K).
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5.3 PK/PD analysis

Change in the bacterial density over time was modeled using STELLA as in figures 5a and
b. the model assumes that bacterial growth over time follows an exponential pattern.

Fig. 5a. STELLA model constructed to investigate the change in bacterial density over time.

Fig. 5b. Bacterial growth curve from the PD model.
The drug effect was added to the previous model through the inclusion of a first order kill rate.
This resulted in a decline in the log10 bacterial density over time. The decline was found to be
governed by the magnitude of the PD model parameters. The effect of the Hill coefficient, the
minimum growth rate, and the maximum growth rate was investigated for both concentration
dependent and time dependent agents. The values of the PD parameters that were used in the
sensitivity analysis are reported in Table 2. The results from the sensitivity analysis are shown
in Figures 6, 7 and 8. It is noticed that as K increases, there is a sharper decline in the bacterial
density due to a faster rate of killing. In addition, on the single dose level, ciprofloxacin
showed greater rate of killing compared to ampicillin (Figure 6).
Similarly, minimum growth rate achieved under high antibiotic concentration was related to
the treatment outcome. Increased minimum growth rate under certain high antibiotic
pressure, led to a decreased antibiotic efficacy. This could be attributed to development of
resistance. It is also noticed that the effect was greater for concentration dependent
antibiotics than the for time dependent agents (Figure 7).
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PD parameter

Hill coefficient (K)

Scenario 1
Scenario 2
Scenario 3

0.5
1
3

Minimum growth
rate (h-1)
-3
-6
-9

Maximum growth
rate (h-1)
0.75
1.2
2

Table 2. Pharmacodynamic parameters incorporated in the sensitivity analysis

Fig. 6. Effect of the Hill coefficient (K) on the treatment outcomes for both Ciprofloxacin and
Ampicillin.

Fig. 7. Effect of variation of minimum growth rate achieved under high antibiotic
concentration on the treatment outcomes for the investigated antibiotics.

www.intechopen.com

Application of Pharmacokinetics/Pharmacodynamics
(PK/PD) in Designing Effective Antibiotic Treatment Regimens

119

In addition to the previously mentioned PD parameters, maximum growth rate of the
bacteria achieved in the absence of antibiotic was an influential parameter. Change in that
parameter could be considered when the effect of the antibiotic on different bacterial strains
is a point of interest. Moreover, it could be important for a single microbial strain. For
instance, it is known that the growth rate of the bacterial biofilm is reduced compared to the
planktonic cultures due to the development of a matrix of extracellular polymeric substance
that is referred to as a slime2. This will result in reduced penetration of the antibiotics as well
as nutrients. Figure 8 augments that by showing that the increase in the maximum growth
rate led to a more susceptible micro-organism and a faster kill by the antibiotic.

Fig. 8. Effect of variation of maximum growth rate of the microorganism on the treatment
outcome with Ciprofloxacin, Tetracycline and Ampicillin.
6. Development of microbial resistance

Development of microbial resistance is a major challenge that faces antibiotic treatments and
causes reduction in the treatment efficacy. In order to simulate cases of bacterial resistance,
MIC values were allowed to vary two and four fold from the original MIC through
conducting a zMIC sensitivity analysis (Table 3). The pharmacokinetic profiles of the five
antibiotics were simulated using the previously mentioned one compartment disposition
model. It is noticed that as the MIC increases, the level of resistance of the microorganism
increases, thus an expected reduction in the rate of kill will occur. Under such
circumstances, the antibiotic may no longer be effective in eradicating the microorganism as
shown in Figure 9
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MIC (µg/mL)
/antibiotic
Ciprofloxacin
Ampicillin
Rifampin
Streptomycin
Tetracycline

Scenario 1

Scenario 2

Scenario 3

0.017
3.4
12
18.5
0.67

0.034
6.8
24
37
1.34

0.068
13.6
48
74
2.68

Table 3. MIC values incorporated in the sensitivity analysis for simulating the development
of resistance.

Fig. 9. Effect of the development of resistance (simulated through increasing zMIC) on the
antimicrobial outcome for the different antibiotics.
7. Design of treatment strategies

Each of the five antibiotics was allowed to follow two treatment scenarios to overcome the
emergence of the resistant microbe (Figure 10) and the treatment outcome was then
evaluated. Treatment modalities included two protocols: the first implemented a method to
increase the AUC/MIC by increasing the doses of the antibiotic. The second allowed the
percentage of time that the drug concentration stays above the MIC to increase by
decreasing the dosing interval while giving small maintenance doses of the antibiotic.
Shown in Figure 10 is a representation of the concentration profiles expected from the
treatment scenarios and in Figures 11a, b, and c are the simulated treatment outcomes
expected from each protocol for three of the antibiotics.
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Fig. 10. Simulation of the concentration time profile for the treatment scenarios proposed to
overcome resistance. 1. Represents original treatment protocol. 2. Represents increasing
AUC>MIC scenario and 3. Represents the case of increased % t>MIC.

Fig. 11a. Simulation of the target outcome for the two treatment scenarios used against the
Rifampin resistance. Upper left: increasing the dose of Rifampin 1.5 folds over 8 hours
interval. Upper right: decreasing the dosing interval to 4 hours while maintaining the
original dose. Down: decreasing the dosing interval to 2 hours while maintaining the
original dose.
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Fig. 11b. Simulation of the treatment outcomes obtained after implementation of the two
treatment scenarios with Ciprofloxacin. Left side curve represents increasing the dose by
four times over 8 hours dosing interval. Right side curve represents decreasing the dosing
interval by 4 hours while maintaining the original dose.
Rifampin is known to be a concentration-dependent antibiotic. Increasing the exposure to the
drug above the MIC (by 1.5 fold increase in the dose) improved the treatment outcome, yet
increasing the percentage of time relative to the dosing interval (tau) that the drug
concentration was above the MIC- by decreasing tau from 8 hours to 4 and 2 hours
simultaneously- did not achieve the target outcome even when the dosing interval decreased
to 2 hours. Ciprofloxacin- a fluoroquinolone known to be a concentration dependent
antibiotic- displayed similar results to Rifampin upon increasing exposure above MIC (four
fold increase in the dose) compared to t>MIC (reducing the dosing interval to 2 hours).
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Fig. 11c. Simulation of the treatment outcomes achieved after increasing Tetracycline dose
(four folds over 8 hours dosing interval, left side curve), or decreasing the dosing interval (2
hours, while maintaining original dose, right side curve).
On the other hand, the efficacy of Tetracycline is known to be time dependent. Therefore,
increasing the percent of time the drug stays above MIC relative to the dosing interval
seems to be more relevant than increasing the exposure above the MIC. Surprisingly, the
two scenarios have achieved nearly the same treatment outcome for microbial resistance
against Tetracycline. Both treatment scenarios succeeded to achieve the target outcome of
three log10 reduction in bacterial density by the end of the antibiotic treatment.
8. Discussion

This study addressed the complex relationship between the exposure to antibiotics and the
growth and death rates of bacteria. PK/PD simulations using STELLA showed that
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although MIC is an important PD parameter, it is not the only parameter that governs the
interaction of the antibiotic and the bacteria. Other PD parameters should additionally be
taken into consideration when designing antibiotic dosage regimens. For instance, Figure 4
showed that three antibiotics with the same MIC (the concentration corresponding to a net
growth of zero) could show different microbiological activity depending on the magnitude
of the Hill coefficient (K). Other PD parameters to be considered are the minimum growth
rate and the maximum growth rate, which can capture effects that cannot be accounted for
by solely considering the MIC and can importantly affect the therapeutic outcomes.
Pharmacodynamic simulations of the antibiotics concentration against net bacterial growth
showed that the shape of the sigmoidal functions differs among antibiotics from different
classes with some of them showing greater sensitivity to changing concentrations
(Ciprofloxacin and Streptomycin) than others (Tetracycline and Ampicillin). The shape of
the pharmacodynamic function is determined by the values of PD parameters displayed in
Table 2.

Additionally, using a STELLA model for the change in bacterial density over time, it was
found that the parameters that govern the PD function have a profound effect on the
microbiological activity. The Hill coefficient influences the sensitivity of the bacteria to the
change in the antibiotic concentration as was shown in Figure 4. Assuming a PK model in
which the drug reaches steady state form the beginning of the treatment, a concentration
that is above the MIC most of the time, and all other parameters are equal, the simulation
predicts that antibiotics with a high Hill coefficient are more effective than those with a low
value of the coefficient.
Considering the minimum bacterial net growth rate at high antibiotic concentrations, the
simulation predicts that antibiotics that induced lower values of minimum bacterial net
growth rate are more effective than those with higher values. Increase in the minimum
bacterial net growth rate could be atrributed to the development of resistance or to the
utilization of ineffective therapy against a specific bacterial strain.

Maximum growth rate in the absence of antibiotic is another important parameter to
consider in the design of antibiotic treatment. That PD parameter is subject to change when
treating different micro-organisms or if the nature of infection by the same microbe has been
changed. Regarding the later condition, biofilm infection could be considered as a change in
the nature of the infection by the same micro-organism5. It is well-known that biofilm is a
type of persistent infections that is developed in chronic disease statuses and is
characterized by a slower rate of growth compared to acute infections2. This phenomenon is
also observed in the in vitro systems- where the planktonic cultured bacteria exhibit a faster
rate of growth compared to the biofilm cultured ones6. Therefore, increasing the maximum
growth rate in the sensitivity analysis has led to a faster kill by different antibiotics due to
the greater exposure of the bacteria to the antibiotic compared to the slowly growing biofilm
infection.
Interestingly enough, estimates of the parameter K was higher for antibiotics that are
concentration dependent (Ciprofloxacin, Rifampin, and Streptomycin) compared to those
that are time dependent (Ampicillin and Tetracycline) which means that the formers are
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characterized by a steeper pharmacodynamic function. The steeper the function, the more
dramatically the bacterial killing is sensitive to the change in antibiotic concentration
above the MIC. Therefore, it could be a reasonable assumption that for antibiotics that
have grater K, increasing the concentration above MIC (AUC/MIC) is the most effective
strategy to improve the treatment outcomes. This hypothesis was fully augmented by the
PK/PD simulation shown in both Figures 11a and b. Increasing the % t>MIC for Rifampin
by reducing the dosing interval to 4 hours and even 2 hours did not achieve the target
outcome for the resistant strain as did the increase in the AUC/MIC. Furthermore,
Ciprofloxacin achieved the target therapeutic outcome only when the dose increased
allowing AUC>MIC to increase. It is worth mentioning that the magnitude of the dose
increase for concentration dependent antibiotics appears to be related to the PD parameter
K (the Hill coefficient); since Rifampin- has a K value of 2.5 compared to 1.1 for
Ciprofloxacin- has achieved the target therapeutic outcome upon 1.5 fold increase in the
dose compared to a four folds increase for Ciprofloxacin. In another way, one can
conclude that as K increases, as the antibiotic efficacy is more sensitive to small changes in
concentration.
On the other hand, it was assumed that lower values of K could be associated with time
dependence of the antibiotics. This assumption is not fully supported by the current
simulation, since for Tetracycline (k=0.61) both scenarios of increasing the AUC/MIC and
% t>MIC worked well and achieved comparable therapeutic outcomes. It is worth
mentioning, however, that the maintenance dose used in the former scenario (12.08 µg
every 8 hours) was four times higher than that used in the later scenario (2.95 µg every 2
hours). Although it is known that longer dosing intervals are more convenient and can
improve patient adherence to therapy, drug toxicity is an important consideration as well.
In case where toxicity is expected from higher doses of a time-dependent antibiotic, the
strategy of dividing the doses into smaller fractions for shorter dosing intervals may be
considered.
Finally, it should be noted that this model may suffer some limitations due to many causes.
The model assumes that the kill rate increases with increasing antibiotic concentration,
however in reality, the development of an adaptive resistance- a mechanism by which the
bacteria becomes increasingly refractory to the antibiotic treatment- may lead to the
decrease in kill rate with time and therefore limit such assumptions. Moreover, the
constitutive and inducible immune defense of the human body contributes to the efficacy of
the antibiotic treatment protocols in a way that could not be fully represented by the current
PK/PD analysis under in vitro conditions.
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